New HIV Vaccine Shows Promise In ‘Landmark’ First-In-Human Trial

A novel vaccine approach for the prevention of HIV has shown promise in Phase I trials. IAVI and Scripps Research reported that the vaccine which is being developed to act as an immune primer, to trigger the activation of naïve B cells via a

Continue reading…